Mini-symposium brings together researchers focused on developing type 1 diabetes therapies that can evade the immune system
Event was part of a series that explores convergent approaches in Medicine by Design’s team projects
Convergent Working Groups bring new voices to Medicine by Design to explore ideas and opportunities in regenerative medicine
New initiative to include social scientists, policy experts, industry leaders, patients and others
Summer by Design gives PhD students and post-doctoral fellows a foundation in the business of regenerative medicine
Research trainees from around the world are encouraged to apply by Jan. 23, 2023
The Medicine by Design symposium in pictures: A celebration of a bold vision for regenerative medicine
Field leaders come together to explore the "Grand Questions in Regenerative Medicine."
Medicine by Design symposium returns in-person to focus on the theme of Grand Questions in Regenerative Medicine
On Dec. 8, the Medicine by Design symposium will explore some of regenerative medicine's most important and challenging questions
People of Medicine by Design: Nabanita Nawar
"We’re trying to understand the biology behind diseases and target the abnormal behavior that actually happens inside the cells."
Medicine by Design-funded researcher partners with Moderna to develop RNA-based tools to treat and prevent disease
Professor Omar F. Khan’s lab group is designing new platforms that deliver RNA to the body, addressing a range of biomedical challenges
adMare Bioinnovations and Medicine by Design partner to support translation priorities in the Toronto life sciences ecosystem
Partnership to accelerate health innovation commercialization in the Toronto life sciences ecosystem and in Canada
Medicine by Design-funded researcher featured on television for World Sight Day
Polymer and tissue regeneration expert discussed her multi-pronged approach to seeking treatments for eye diseases
Op-ed: There are no overnight successes in science — medical research needs more stable funding
Medicine by Design’s Scientific Director, Michael Sefton, publishes an op-ed in the Hill Times.
People of Medicine by Design: Katie Lye
"I hope that my work will one day be used across a wide range of applications. With all the complexities and unknowns of degenerative diseases, it’s important for us to explore new ideas."
Recipients of third round of Medicine by Design’s Pivotal Experiment Fund announced
Fund advances research discoveries to real benefit for human health
Medicine by Design launches funding for Convergent Working Groups to take strategic action in regenerative medicine
Convergent Working Groups aim to bring wide-ranging expertise and perspectives together
Medicine by Design announces new strategic plan to advance regenerative medicine and transform healthcare globally
Community collaboration drove the new commitments in bold five-year plan
Immunology expert is Medicine by Design’s newest investigator
Matthew Buechler recently joined the Department of Immunology as an assistant professor.